Len May is the CEO at Endocanna Health, the world’s first and most comprehensive personalization platform focusing on the Endocannabinoid System tailored to your DNA. This makes Endocanna Health, Inc. the future of precision cannabinoid therapeutics.
Topics Discussed:
- How the 500+ compounds found in cannabis (i.e. cannabinoids, terpenes, flavonoids) work in concert with our DNA
- Adverse effects of cannabis such as Cannabinoid Hyperemesis Syndrome (CHS) and what the causes may be
- ECS and how pain can be related to stress
- The company’s Endo-DNA screening, which maps your Endocannabinoid System (ECS) to match specific cannabinoid ratios and terpene profiles in cannabis products that are aligned with your unique genotype
